CXCL13 and viral infectious disease: Histopathological analyses demonstrated that mice vaccinated with HA-circRNA, although surviving the viral challenge, still observed very mild pneumonia induced by viral infection, whereas mice vaccinated with HA-CXCL13-circRNA avoided lung injury (Fig. 5F).